197 related articles for article (PubMed ID: 8923487)
1. Interactions between tachykinins and diverse, human nicotinic acetylcholine receptor subtypes.
Lukas RJ; Eisenhour CM
Neurochem Res; 1996 Oct; 21(10):1245-57. PubMed ID: 8923487
[TBL] [Abstract][Full Text] [Related]
2. Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes.
Ke L; Lukas RJ
J Neurochem; 1996 Sep; 67(3):1100-12. PubMed ID: 8752117
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line.
Lukas RJ
J Neurochem; 1991 Apr; 56(4):1134-45. PubMed ID: 2002334
[TBL] [Abstract][Full Text] [Related]
4. The "calcium antagonist" TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes.
Bencherif M; Eisenhour CM; Prince RJ; Lippiello PM; Lukas RJ
J Pharmacol Exp Ther; 1995 Dec; 275(3):1418-26. PubMed ID: 8531111
[TBL] [Abstract][Full Text] [Related]
5. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine.
Fryer JD; Lukas RJ
J Pharmacol Exp Ther; 1999 Jan; 288(1):88-92. PubMed ID: 9862757
[TBL] [Abstract][Full Text] [Related]
6. Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.
Fryer JD; Lukas RJ
J Neurochem; 1999 Mar; 72(3):1117-24. PubMed ID: 10037483
[TBL] [Abstract][Full Text] [Related]
7. Cytochalasin modulation of nicotinic cholinergic receptor expression and muscarinic receptor function in human TE671/RD cells: a possible functional role of the cytoskeleton.
Bencherif M; Lukas RJ
J Neurochem; 1993 Sep; 61(3):852-64. PubMed ID: 8360687
[TBL] [Abstract][Full Text] [Related]
8. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels.
Lukas RJ; Audhya T; Goldstein G; Lucero L
Mol Pharmacol; 1990 Dec; 38(6):887-94. PubMed ID: 1701215
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment.
Ke L; Eisenhour CM; Bencherif M; Lukas RJ
J Pharmacol Exp Ther; 1998 Aug; 286(2):825-40. PubMed ID: 9694939
[TBL] [Abstract][Full Text] [Related]
10. Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line.
Lukas RJ
J Pharmacol Exp Ther; 1993 Apr; 265(1):294-302. PubMed ID: 8474012
[TBL] [Abstract][Full Text] [Related]
11. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma.
Lukas RJ
J Pharmacol Exp Ther; 1989 Oct; 251(1):175-82. PubMed ID: 2571716
[TBL] [Abstract][Full Text] [Related]
13. Subtypes and excitation-contraction coupling mechanisms for neurokinin receptors in smooth muscle of the guinea-pig Taenia caeci.
Hall JM; Morton IK
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):225-34. PubMed ID: 1719434
[TBL] [Abstract][Full Text] [Related]
14. Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors.
Gentry CL; Wilkins LH; Lukas RJ
J Pharmacol Exp Ther; 2003 Jan; 304(1):206-16. PubMed ID: 12490593
[TBL] [Abstract][Full Text] [Related]
15. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
[TBL] [Abstract][Full Text] [Related]
16. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
[TBL] [Abstract][Full Text] [Related]
17. Tachykinin receptors in the small intestine of the cane toad (Bufo marinus): a radioligand binding and functional study.
Burcher E; Warner FJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):692-700. PubMed ID: 9686947
[TBL] [Abstract][Full Text] [Related]
18. Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes.
Gentry CL; Lukas RJ
J Pharmacol Exp Ther; 2001 Dec; 299(3):1038-48. PubMed ID: 11714893
[TBL] [Abstract][Full Text] [Related]
19. Inducible, heterologous expression of human alpha7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line.
Peng JH; Lucero L; Fryer J; Herl J; Leonard SS; Lukas RJ
Brain Res; 1999 Apr; 825(1-2):172-9. PubMed ID: 10216184
[TBL] [Abstract][Full Text] [Related]
20. Regulation of nicotinic receptor subtypes following chronic nicotinic agonist exposure in M10 and SH-SY5Y neuroblastoma cells.
Warpman U; Friberg L; Gillespie A; Hellström-Lindahl E; Zhang X; Nordberg A
J Neurochem; 1998 May; 70(5):2028-37. PubMed ID: 9572289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
